Statin Use After Diabetes Diagnosis Linked to Lower Dementia Risk

A Danish research team conducted a nationwide observational study to assess whether starting statin therapy at different times after a type 2 diabetes diagnosis affects dementia risk.

The study compared individuals who began statins within one year of diagnosis, those who started between one and five years, and those who did not use statins during the first five years after diagnosis. The analysis included over 130,000 people in Denmark who had not previously used statins and were newly diagnosed with type 2 diabetes.

Researchers estimated the 10-year absolute risk of developing dementia for each group. Those who started statins early had the lowest estimated risk, while those who did not use statins had the highest. The findings suggest a potential association between the timing of statin initiation and dementia outcomes in this population.

The study found that early statin initiation was associated with a lower relative risk of dementia compared to no statin use. Late initiation also showed a reduced risk, but the effect was smaller than for early starters. The absolute differences in risk were modest across the groups.

What the numbers show

• 132,585 individuals with type 2 diabetes were included in the study.
• 10-year dementia risk: 3.9% (no statin), 3.5% (late), 3.3% (early.
• Early statin use linked to 15% lower relative dementia risk at 10 years.
• Late statin use linked to 10% lower relative dementia risk at 10 years.
• Absolute risk difference: 0.59% (early), 0.38% (late) lower than no statin.

The authors of the study stated that their findings are based on observational data and that randomized controlled trials are needed to confirm whether starting statins soon after diabetes diagnosis directly reduces dementia risk. They emphasized the importance of further research to establish causality.

In the study, the group that did not use statins within five years of diagnosis had the highest estimated dementia risk after a decade. Both early and late statin initiation were associated with lower risks, but the largest reduction was seen in those who started treatment within the first year.

A geriatrician commented that the results indicate a possible link between early statin use and lower dementia risk, particularly for vascular dementia. However, the geriatrician also noted that the study does not establish a cause-and-effect relationship between statin use and dementia prevention.

The researchers concluded that while their results point to an association, clinical trials are needed to determine if early statin therapy should be recommended specifically to lower dementia risk in people with type 2 diabetes.

* This article is based on publicly available information at the time of writing.